|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 120.69 CHF | +0.06% |
|
+0.75% | +10.13% |
| 07:06am | The V for victory, at least on the charts | |
| 11:20pm | US FDA expands approval for Travere's drug for rare kidney disease | RE |
MarketScreener Strategies
Search
| Novartis: Expect Novartis to keep pushing the envelope | February 20, 2026 at 10:00 am | |
| Novartis: Markets happy with Novartis's delivery | February 04, 2026 at 04:40 pm | |
| Novartis target price raised after upgrades | December 05, 2025 at 04:23 pm | |
![]() | Novartis: The Swiss pharmaceutical giant invests in the future | June 16, 2025 at 10:06 am |
| Novartis AG : Sandoz takes its first steps on the stock exchange | October 04, 2023 at 03:32 pm | |
| Novartis AG : Back to basics | August 17, 2020 at 01:14 pm |
No results for this search
Filters
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition


















